Your browser version may not work well with NCBI's Web applications. More information here...
1: Bioorg Med Chem Lett. 2008 Jun 1;18(11):3431-5. Epub 2008 Apr 8.Click here to read Links

Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones.

Zhao S, Shen Y, van Oeveren A, Marschke KB, Zhi L.

Discovery Research, Ligand Pharmaceuticals Inc., 10275 Science Center Drive, San Diego, CA 92121, USA. szhao2005@gmail.com

A novel oxachrysenone series (2) of nonsteroidal selective androgen receptor modulators (SARM) was developed based on the 6-aryl-2-quinolinones (1). Synthesis and preliminary SAR results based on in vitro assays are discussed. In the cotransfection assay, lead compound 5d showed AR agonist activity more potent than dihydrotestosterone (DHT), whereas compound 17b was a potent antagonist similar to bicalutamide.

PMID: 18442912 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Bicalutamide (Casodex® )

    Bicalutamide is used with another medication (luteinizing hormone-releasing hormone [LHRH]; such as leuprolide or goserelin) to treat metastatic prostate cancer (cancer that started in the prostate and has spread to othe...

  • Source: AHFS Consumer Medication Information